$15.68
0.19% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
IL0011595993
Symbol
INMD

Inmode Stock price

$15.68
-1.24 7.33% 1M
-7.08 31.11% 6M
-6.56 29.50% YTD
-23.72 60.20% 1Y
-51.21 76.56% 3Y
+3.61 29.91% 5Y
+8.90 131.10% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
+0.03 0.19%
ISIN
IL0011595993
Symbol
INMD
Sector

Key metrics

Market capitalization $1.33b
Enterprise Value $603.29m
P/E (TTM) P/E ratio 9.03
EV/FCF (TTM) EV/FCF 3.71
EV/Sales (TTM) EV/Sales 1.45
P/S ratio (TTM) P/S ratio 3.18
P/B ratio (TTM) P/B ratio 1.77
Revenue growth (TTM) Revenue growth -16.16%
Revenue (TTM) Revenue $416.63m
EBIT (operating result TTM) EBIT $134.06m
Free Cash Flow (TTM) Free Cash Flow $162.82m
Cash position $729.21m
EPS (TTM) EPS $1.74
P/E forward 9.26
P/S forward 3.14
EV/Sales forward 1.43
Short interest 8.77%
Show more

Is Inmode a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Inmode Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Inmode forecast:

2x Buy
33%
4x Hold
67%

Analyst Opinions

6 Analysts have issued a Inmode forecast:

Buy
33%
Hold
67%

Financial data from Inmode

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
417 417
16% 16%
100%
- Direct Costs 74 74
8% 8%
18%
343 343
18% 18%
82%
- Selling and Administrative Expenses 194 194
1% 1%
47%
- Research and Development Expense 14 14
7% 7%
3%
135 135
37% 37%
32%
- Depreciation and Amortization 0.59 0.59
22% 22%
0%
EBIT (Operating Income) EBIT 134 134
37% 37%
32%
Net Profit 149 149
18% 18%
36%

In millions USD.

Don't miss a Thing! We will send you all news about Inmode directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inmode Stock News

Neutral
Seeking Alpha
one day ago
InMode stock has significant upside potential due to its low valuation, profitability, share buybacks, and potential benefits from expected interest rate cuts. INMD's business model involves selling high-quality, expensive medical devices for aesthetic procedures, heavily influenced by interest rates due to customer financing. The stock's decline was driven by underutilized buybacks, declining ...
Neutral
PRNewsWire
3 days ago
YOKNEAM, Israel , Sept. 4, 2024 /PRNewswire/ -- InMode Ltd.
Neutral
PRNewsWire
about one month ago
YOKNEAM, Israel , Aug. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events in August: 9th Annual Needham Virtual MedTech & Diagnostics Conference Presenters: Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer Format: Virtual...
More Inmode News

Company Profile

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Head office Israel
CEO Moshe Mizrahy
Employees 581
Founded 2008
Website www.inmodemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today